142 related articles for article (PubMed ID: 9142200)
21. Persistence of peripheral blood and bone marrow blasts during remission induction in adult acute lymphoblastic leukemia confers a poor prognosis depending on treatment intensity.
Cortes J; Fayad L; O'Brien S; Keating M; Kantarjian H
Clin Cancer Res; 1999 Sep; 5(9):2491-7. PubMed ID: 10499624
[TBL] [Abstract][Full Text] [Related]
22. Childhood acute lymphoblastic leukemia: are routine end-of-therapy bone marrow and cerebrospinal fluid examinations necessary?
Hutt PJ; Sabio H; Gilchrist GS; O'Brien C
Mayo Clin Proc; 1996 Sep; 71(9):854-6. PubMed ID: 8790260
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of persistent peripheral blood and bone marrow lymphoblasts on day 15 of therapy in childhood acute lymphoblastic leukemia as detected by flow cytometry.
Jaworska-Posadzy A; Styczynski J; Kubicka M; Debski R; Rafinska-Kurylo B; Kolodziej B; Pogorzala M; Wysocki M
Anticancer Res; 2011 Apr; 31(4):1453-7. PubMed ID: 21508402
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of early treatment response in children with acute lymphoblastic leukemia: a single institution experience in Shanghai, China.
Tie LJ; Gu LJ; Song DL; Jiang LM; Xue HL; Tang JY; Dong L; Pan C; Chen J; Ye H; Chen J
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jan; 11(1):5-9. PubMed ID: 19149913
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of early marrow response in childhood aneuploid acute lymphoblastic leukemia: flow cytometric DNA analysis versus standard morphology.
Finn LS; Hawkins DS; Rutledge JC; Patterson K
Pediatr Dev Pathol; 2004; 7(1):39-47. PubMed ID: 15255034
[TBL] [Abstract][Full Text] [Related]
26. CD4
Niedźwiecki M; Budziło O; Zieliński M; Adamkiewicz-Drożyńska E; Maciejka-Kembłowska L; Szczepański T; Trzonkowski P
J Immunol Res; 2018; 2018():1292404. PubMed ID: 30003111
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of early response to chemotherapy assessed by the day 15 bone marrow aspiration in adult acute lymphoblastic leukemia: a prospective analysis of 437 cases and its application for designing induction chemotherapy trials.
Sebban C; Browman GP; Lepage E; Fière D
Leuk Res; 1995 Nov; 19(11):861-8. PubMed ID: 8551804
[TBL] [Abstract][Full Text] [Related]
28. Bone marrow biopsy as prognostic indicator in childhood acute lymphoblastic leukemia--another opinion.
Rizzari C; Conter V
Med Pediatr Oncol; 1998 May; 30(5):315-7. PubMed ID: 9544233
[No Abstract] [Full Text] [Related]
29. Monitoring treatment response of childhood precursor B-cell acute lymphoblastic leukemia in the AIEOP-BFM-ALL 2000 protocol with multiparameter flow cytometry: predictive impact of early blast reduction on the remission status after induction.
Ratei R; Basso G; Dworzak M; Gaipa G; Veltroni M; Rhein P; Biondi A; Schrappe M; Ludwig WD; Karawajew L;
Leukemia; 2009 Mar; 23(3):528-34. PubMed ID: 19020543
[TBL] [Abstract][Full Text] [Related]
30. [Intracellular retention of cytarabine-triphosphate (Ara-CTP) in blasts of children with acute lymphoblastic leukemia. Correlation with clinical course parameters].
Schiller M; Hohenlöchter B; Schulze-Westhoff P; Zimmermann M; Ritter J; Jürgens H; Boos J
Klin Padiatr; 1996; 208(4):151-9. PubMed ID: 8926681
[TBL] [Abstract][Full Text] [Related]
31. Day-6 bone marrow aspirate for the prediction of response to remission induction therapy for acute myelogenous leukaemia.
Peters WG; Willemze R; Zwaan FE; Colly LP
Blut; 1988 Aug; 57(2):91-5. PubMed ID: 3165680
[TBL] [Abstract][Full Text] [Related]
32. Prediction of outcomes by early treatment responses in childhood T-cell acute lymphoblastic leukemia: a retrospective study in China.
Wei W; Chen X; Zou Y; Chang L; An W; Wan Y; Liu T; Yang W; Chen Y; Guo Y; Zhu X
BMC Pediatr; 2015 Jul; 15():80. PubMed ID: 26174476
[TBL] [Abstract][Full Text] [Related]
33. Comparison of prognostic value of in vitro drug resistance and bone marrow residual disease on day 15 of therapy in childhood acute lymphoblastic leukemia.
Styczynski J; Piatkowska M; Jaworska-Posadzy A; Czyzewski K; Kubicka M; Kolodziej B; Kurylo-Rafinska B; Debski R; Pogorzala M; Wysocki M
Anticancer Res; 2012 Dec; 32(12):5495-9. PubMed ID: 23225457
[TBL] [Abstract][Full Text] [Related]
34. Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12 months of the completion of primary therapy: Children's Oncology Group study CCG-1941.
Gaynon PS; Harris RE; Altman AJ; Bostrom BC; Breneman JC; Hawks R; Steele D; Zipf T; Stram DO; Villaluna D; Trigg ME
J Clin Oncol; 2006 Jul; 24(19):3150-6. PubMed ID: 16717292
[TBL] [Abstract][Full Text] [Related]
35. The dose related effect of steroids on blast reduction rate and event free survival in children with acute lymphoblastic leukemia.
Yetgin S; Cetin M
Leuk Lymphoma; 2003 Mar; 44(3):489-95. PubMed ID: 12688320
[TBL] [Abstract][Full Text] [Related]
36. [Prognostic value of both detection of lymphoblasts in the period of early treatment and minimal residual disease in childhood acute lymphoblastic leukemia].
Tie LJ; Gu LJ; Song DL; Jiang LM; Xue HL; Tang JY; Dong L; Pan C; Chen J; Ye H; Wang YP; Chen J
Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):6-9. PubMed ID: 15946500
[TBL] [Abstract][Full Text] [Related]
37. Residual disease at the end of induction therapy as a predictor of relapse during therapy in childhood B-lineage acute lymphoblastic leukemia.
Wasserman R; Galili N; Ito Y; Silber JH; Reichard BA; Shane S; Womer RB; Lange B; Rovera G
J Clin Oncol; 1992 Dec; 10(12):1879-88. PubMed ID: 1453203
[TBL] [Abstract][Full Text] [Related]
38. Outcome after first relapse in children with acute lymphoblastic leukemia: a population-based study of 315 patients from the Nordic Society of Pediatric Hematology and Oncology (NOPHO).
Schroeder H; Garwicz S; Kristinsson J; Siimes MA; Wesenberg F; Gustafsson G
Med Pediatr Oncol; 1995 Nov; 25(5):372-8. PubMed ID: 7674994
[TBL] [Abstract][Full Text] [Related]
39. [The prognostic significance of parameters of bone marrow blast cell proliferation in patients with acute leukemia].
Kotel'nikov VM; Abakumov EM; Isaev VG; Morozova NG; Timkina EN
Gematol Transfuziol; 1989 Nov; 34(11):14-8. PubMed ID: 2612858
[TBL] [Abstract][Full Text] [Related]
40. [Concept and interim result of the ALL-BFM 90 therapy study in treatment of acute lymphoblastic leukemia in children and adolescents: the significance of initial therapy response in blood and bone marrow].
Schrappe M; Reiter A; Sauter S; Ludwig WD; Wörmann B; Harbott J; Bender-Götze C; Dörffel W; Dopfer R; Frey E
Klin Padiatr; 1994; 206(4):208-21. PubMed ID: 7526027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]